Anahita Bassir Nia, MD
Biography
Research & Publications
News
Appointments
Biography
Anahita Bassir Nia, MD, is an Addiction Psychiatrist and Assistant Professor of Psychiatry, at Yale School of Medicine. She is, currently, working as the Assistant Clinical Unit Chief, and Assistant Director for Training and Education, at the Clinical Neuroscience Research Unit (CNRU), Connecticut Mental Health Hospital (CMHC).
Dr. Bassir Nia has focused her research on translational science to understand the neurobiology of substance use disorders in relation to chronic stress, trauma and other contributing social factors. She is a scholar at the Clinician Scientist Training Program (CSTP) at Yale University and has received her career development award to study the endogenous cannabinoid system (eCB) in opioid use disorder (OUD) with the ultimate goal of targeting this system to develop novel therapeutic options in OUD treatment.
She is also interested in the potential use of psychedelics in treatment of substance use disorders, particularly alcohol use disorder (AUD) and OUD. She studies the potential effects of psychedelics N, N-Dimethyltryptamine (DMT) on AUD and its underlying mechanism such as changes in neuroplasticity.
Another line of Dr. Bassir Nia's research is focused on understanding the neurobiology of post-traumatic stress disorder (PTSD) and the role of the endocannabinoid (eCB) system dysregulations in psychopathology of PTSD. She investigated the differential effects of childhood vs. adulthood trauma on the eCB system, which could have important clinical implications in targeting the eCB system in PTSD treatment.
Education & Training
- Addiction Psychiatry Fellowship- Academic TrackIcahn School of Medicine at Mount Sinai West (2018)
- Psychiatry ResidencyIcahn School of Medicine at Mount Sinai Beth Israel (2016)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Mentorship award | Research in Addiction Medicine Scholars (RAMS) Program | 2021 |
Travel award | College on Problems of Drug Dependence (CPDD) | 2020 |
New Investigator Award (NIA) | American Society of Clinical Psychopharmacology (ASCP) | 2020 |
Career Development Award (K12) | NIDA | 2019 |
Research in Addiction Medicine Scholars (RAMS) Program fellowship award (2016) | Boston University School of Medicine, supported by a grant from the National Institute on Drug Abuse (NIDA) | 2017 |
Junior Investigators Award | American Psychiatric Association (APA), American College of Neuropsychopharmacology (ACNP), and Society of Biological Psychiatry (SOBP) | 2017 |
Travel Award | American Society of Clinical Psychopharmacology (ASCP), American College of Neuropsychopharmacology (ACNP) and the Zucker Hillside Hospital. | 2017 |
Travel award | American Academy of Addiction Psychiatry (AAAP) | 2016 |
Travel Award | Icahn School of Medicine | 2016 |
Professional Service
Organization | Role | Date |
---|---|---|
Current Addiction Reports | Editor | 2023 - Present |
Journal Cellular and Molecular Life Sciences | Guest Editor | 2023 - Present |
Society of Biological Psychiatry (SOBP) | Committee Member | 2022 - Present |
Frontiers in Psychiatry | Guest Editor | 2022 - Present |
NIH | Pathophysiological Basis of Mental Disorders and Addictions Study Section | 2021 |
College on Problems of Drug Dependence (CPDD) | Human Research Committee: to identify issues relating to clinical research in the drug abuse field and recommend actions to the Board of Directors. | 2021 - Present |
Scientific Advisory Board, Synendos Therapeutics | Board Member | 2021 - Present |
American Academy of Addiction Psychiatry | Cannabis Interest Committee | 2019 - Present |
College on Problems of Drug Dependence | Publication Committee | 2018 - Present |
IRB | Member | 2018 - Present |
American Society of Clinical Psychopharmacology (ASCP) | CME/Meeting Committee and Program Committee | 2017 - Present |
Departments & Organizations
- Janeway Society
- Neuroscience Research Training Program (NRTP)
- Psychiatry
- Yale Center for the Science of Cannabis and Cannabinoids
- Yale Medicine